Prostate Cancer Prevention and Finasteride: A Conversation with NCI’s Dr. Howard Parnes


The Prostate Cancer Prevention Trial showed that finasteride can reduce the risk of prostate cancer, but might increase the risk of aggressive disease. NCI’s Howard Parnes talks about subsequent findings and what they mean for men aged 55 and older.

Powered by WPeMatico